189 related articles for article (PubMed ID: 33033656)
1. Deep Learning to Estimate Human Epidermal Growth Factor Receptor 2 Status from Hematoxylin and Eosin-Stained Breast Tissue Images.
Anand D; Kurian NC; Dhage S; Kumar N; Rane S; Gann PH; Sethi A
J Pathol Inform; 2020; 11():19. PubMed ID: 33033656
[TBL] [Abstract][Full Text] [Related]
2. Prediction of clinicopathological features, multi-omics events and prognosis based on digital pathology and deep learning in HR
Hu J; Lv H; Zhao S; Lin CJ; Su GH; Shao ZM
J Thorac Dis; 2023 May; 15(5):2528-2543. PubMed ID: 37324098
[TBL] [Abstract][Full Text] [Related]
3. Automated segmentation of cell membranes to evaluate HER2 status in whole slide images using a modified deep learning network.
Khameneh FD; Razavi S; Kamasak M
Comput Biol Med; 2019 Jul; 110():164-174. PubMed ID: 31163391
[TBL] [Abstract][Full Text] [Related]
4. HAHNet: a convolutional neural network for HER2 status classification of breast cancer.
Wang J; Zhu X; Chen K; Hao L; Liu Y
BMC Bioinformatics; 2023 Sep; 24(1):353. PubMed ID: 37730567
[TBL] [Abstract][Full Text] [Related]
5. SlideGraph
Lu W; Toss M; Dawood M; Rakha E; Rajpoot N; Minhas F
Med Image Anal; 2022 Aug; 80():102486. PubMed ID: 35640384
[TBL] [Abstract][Full Text] [Related]
6. Prediction of HER2-positive breast cancer recurrence and metastasis risk from histopathological images and clinical information via multimodal deep learning.
Yang J; Ju J; Guo L; Ji B; Shi S; Yang Z; Gao S; Yuan X; Tian G; Liang Y; Yuan P
Comput Struct Biotechnol J; 2022; 20():333-342. PubMed ID: 35035786
[TBL] [Abstract][Full Text] [Related]
7. AutoIHC-Analyzer: computer-assisted microscopy for automated membrane extraction/scoring in HER2 molecular markers.
Tewary S; Arun I; Ahmed R; Chatterjee S; Mukhopadhyay S
J Microsc; 2021 Jan; 281(1):87-96. PubMed ID: 32803890
[TBL] [Abstract][Full Text] [Related]
8. Deep learning identifies morphological features in breast cancer predictive of cancer ERBB2 status and trastuzumab treatment efficacy.
Bychkov D; Linder N; Tiulpin A; Kücükel H; Lundin M; Nordling S; Sihto H; Isola J; Lehtimäki T; Kellokumpu-Lehtinen PL; von Smitten K; Joensuu H; Lundin J
Sci Rep; 2021 Feb; 11(1):4037. PubMed ID: 33597560
[TBL] [Abstract][Full Text] [Related]
9. Artificial Intelligence Algorithms to Assess Hormonal Status From Tissue Microarrays in Patients With Breast Cancer.
Shamai G; Binenbaum Y; Slossberg R; Duek I; Gil Z; Kimmel R
JAMA Netw Open; 2019 Jul; 2(7):e197700. PubMed ID: 31348505
[TBL] [Abstract][Full Text] [Related]
10. Use of Deep Learning to Develop and Analyze Computational Hematoxylin and Eosin Staining of Prostate Core Biopsy Images for Tumor Diagnosis.
Rana A; Lowe A; Lithgow M; Horback K; Janovitz T; Da Silva A; Tsai H; Shanmugam V; Bayat A; Shah P
JAMA Netw Open; 2020 May; 3(5):e205111. PubMed ID: 32432709
[TBL] [Abstract][Full Text] [Related]
11. Comparative analysis of machine learning approaches to classify tumor mutation burden in lung adenocarcinoma using histopathology images.
Sadhwani A; Chang HW; Behrooz A; Brown T; Auvigne-Flament I; Patel H; Findlater R; Velez V; Tan F; Tekiela K; Wulczyn E; Yi ES; Mermel CH; Hanks D; Chen PC; Kulig K; Batenchuk C; Steiner DF; Cimermancic P
Sci Rep; 2021 Aug; 11(1):16605. PubMed ID: 34400666
[TBL] [Abstract][Full Text] [Related]
12. HER2 Molecular Marker Scoring Using Transfer Learning and Decision Level Fusion.
Tewary S; Mukhopadhyay S
J Digit Imaging; 2021 Jun; 34(3):667-677. PubMed ID: 33742331
[TBL] [Abstract][Full Text] [Related]
13. Lung Cancer Diagnosis on Virtual Histologically Stained Tissue Using Weakly Supervised Learning.
Chen Z; Wong IHM; Dai W; Lo CTK; Wong TTW
Mod Pathol; 2024 Apr; 37(6):100487. PubMed ID: 38588884
[TBL] [Abstract][Full Text] [Related]
14. Determining breast cancer biomarker status and associated morphological features using deep learning.
Gamble P; Jaroensri R; Wang H; Tan F; Moran M; Brown T; Flament-Auvigne I; Rakha EA; Toss M; Dabbs DJ; Regitnig P; Olson N; Wren JH; Robinson C; Corrado GS; Peng LH; Liu Y; Mermel CH; Steiner DF; Chen PC
Commun Med (Lond); 2021; 1():14. PubMed ID: 35602213
[TBL] [Abstract][Full Text] [Related]
15. HEROHE Challenge: Predicting HER2 Status in Breast Cancer from Hematoxylin-Eosin Whole-Slide Imaging.
Conde-Sousa E; Vale J; Feng M; Xu K; Wang Y; Della Mea V; La Barbera D; Montahaei E; Baghshah M; Turzynski A; Gildenblat J; Klaiman E; Hong Y; Aresta G; Araújo T; Aguiar P; Eloy C; Polónia A
J Imaging; 2022 Jul; 8(8):. PubMed ID: 36005456
[TBL] [Abstract][Full Text] [Related]
16. Vision Transformers for Breast Cancer Human Epidermal Growth Factor Receptor 2 Expression Staging without Immunohistochemical Staining.
Ayana G; Lee E; Choe SW
Am J Pathol; 2024 Mar; 194(3):402-414. PubMed ID: 38096984
[TBL] [Abstract][Full Text] [Related]
17. Prediction of genetic alterations from gastric cancer histopathology images using a fully automated deep learning approach.
Jang HJ; Lee A; Kang J; Song IH; Lee SH
World J Gastroenterol; 2021 Nov; 27(44):7687-7704. PubMed ID: 34908807
[TBL] [Abstract][Full Text] [Related]
18. Prediction of clinically actionable genetic alterations from colorectal cancer histopathology images using deep learning.
Jang HJ; Lee A; Kang J; Song IH; Lee SH
World J Gastroenterol; 2020 Oct; 26(40):6207-6223. PubMed ID: 33177794
[TBL] [Abstract][Full Text] [Related]
19. Deep learning-enabled breast cancer hormonal receptor status determination from base-level H&E stains.
Naik N; Madani A; Esteva A; Keskar NS; Press MF; Ruderman D; Agus DB; Socher R
Nat Commun; 2020 Nov; 11(1):5727. PubMed ID: 33199723
[TBL] [Abstract][Full Text] [Related]
20. HER2 challenge contest: a detailed assessment of automated HER2 scoring algorithms in whole slide images of breast cancer tissues.
Qaiser T; Mukherjee A; Reddy Pb C; Munugoti SD; Tallam V; Pitkäaho T; Lehtimäki T; Naughton T; Berseth M; Pedraza A; Mukundan R; Smith M; Bhalerao A; Rodner E; Simon M; Denzler J; Huang CH; Bueno G; Snead D; Ellis IO; Ilyas M; Rajpoot N
Histopathology; 2018 Jan; 72(2):227-238. PubMed ID: 28771788
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
